REFERENCES
1. Jivraj S, Rai R, Underwood J, Regan L. Genetic thrombophilic
mutations among couples with recurrent miscarriage. Hum Reprod.
2006;21(5):1161-5.
2. Ormesher L, Simcox L, Tower C, Greer IA. Management of inherited
thrombophilia in pregnancy. Womens Health (Lond). 2016;12(4):433-41.
3. Cunningham FG. ea Williams Obstetrics. 24th ed: McGraw-hill
Education; 2014. p. 350-75.
4. Alhalaki W, Altanoukhi IA, Alhalabi M. The association of activated
protein C resistance (aPCR) with recurrent pregnancy loss in syrian
population. Inter J Pharma Sci Rev Res. 2016;38(151):290-5.
5. D’Uva M, Di Micco P, Strina I, Ranieri A, Alviggi C, Mollo A, et al.
Etiology of hypercoagulable state in women with recurrent fetal loss
without other causes of miscarriage from Southern Italy: new clinical
target for antithrombotic therapy. Biologics. 2008;2(4):897-902.
6. Bloomenthal D, von Dadelszen P, Liston R, Magee L, Tsang P. The
effect of factor V Leiden carriage on maternal and fetal health. Cmaj.
2002;167(1):48-54.
7. Turki RF, Assidi M, Banni HA, Zahed HA, Karim S, Schulten HJ, et al.
Associations of recurrent miscarriages with chromosomal abnormalities,
thrombophilia allelic polymorphisms and/or consanguinity in Saudi
Arabia. BMC Med Genet. 2016;17(Suppl 1):69.
8. Kacprzak M, Chrzanowska M, Skoczylas B, Moczulska H, Borowiec M,
Sieroszewski P. Genetic causes of recurrent miscarriages. Ginekol Pol.
2016;87(10):722-6.
9. Wolski H, Barlik M, Drews K, Klejewski A, Kurzawińska G, Ożarowski M,
et al. Contribution of inherited thrombophilia to recurrent miscarriage
in the Polish population. Ginekol Pol. 2017;88(7):385-92.
10. Sergi C, Al Jishi T, Walker M. Factor V Leiden mutation in women
with early recurrent pregnancy loss: a meta-analysis and systematic
review of the causal association. Arch Gynecol Obstet.
2015;291(3):671-9.
11. Kirkpatrick LA, Feeney BC. A simple guide to IBM SPSS statistics for
version 20.0. Student ed. Belmont, Calif.: Wadsworth, Cengage Learning;
2013.
12. Christiansen OB, Steffensen R, Nielsen HS, Varming K. Multifactorial
etiology of recurrent miscarriage and its scientific and clinical
implications. Gynecol Obstet Invest. 2008;66(4):257-67.
13. Park WC, Chang JH. Clinical Implications of
Methylenetetrahydrofolate Reductase Mutations and Plasma Homocysteine
Levels in Patients with Thromboembolic Occlusion. Vasc Specialist Int.
2014;30(4):113-9.
14. Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli
I, et al. Inherited thrombophilia and pregnancy complications revisited.
Obstet Gynecol. 2008;112(2 Pt 1):320-4.
15. Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity
in fertility and pregnancy. Nat Clin Pract Endocrinol Metab.
2008;4(7):394-405.
16. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G, Jr.,
et al. The relationship of the factor V Leiden mutation and pregnancy
outcomes for mother and fetus. Obstet Gynecol. 2005;106(3):517-24.
17. Micco PD, D’Uva M. Recurrent pregnancy loss and thrombophilia. Open
Atherosclerosis & Thrombosis J 2009;2(1):33-5.
18. Lissak A, Sharon A, Fruchter O, Kassel A, Sanderovitz J, Abramovici
H. Polymorphism for mutation of cytosine to thymine at location 677 in
the methylenetetrahydrofolate reductase gene is associated with
recurrent early fetal loss. Am J Obstet Gynecol. 1999;181(1):126-30.
19. Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thomas CM, Borm GF, et
al. Hyperhomocysteinemia: a risk factor in women with unexplained
recurrent early pregnancy loss. Fertil Steril. 1993;60(5):820-5.
20. Makino A, Nakanishi T, Sugiura-Ogasawara M, Ozaki Y, Suzumori N,
Suzumori K. No association of C677T methylenetetrahydrofolate reductase
and an endothelial nitric oxide synthase polymorphism with recurrent
pregnancy loss. Am J Reprod Immunol. 2004;52(1):60-6.
21. Ren A, Wang J. Methylenetetrahydrofolate reductase C677T
polymorphism and the risk of unexplained recurrent pregnancy loss: a
meta-analysis. Fertil Steril. 2006;86(6):1716-22.
22. Silver RM, Zhao Y, Spong CY, Sibai B, Wendel G, Jr., Wenstrom K, et
al. Prothrombin gene G20210A mutation and obstetric complications.
Obstet Gynecol. 2010;115(1):14-20.
23. Rodger MA, Hague WM, Kingdom J, Kahn SR, Karovitch A, Sermer M, et
al. Antepartum dalteparin versus no antepartum dalteparin for the
prevention of pregnancy complications in pregnant women with
thrombophilia (TIPPS): a multinational open-label randomised trial.
Lancet. 2014;384(9955):1673-83.
24. Roque H, Paidas MJ, Funai EF, Kuczynski E, Lockwood CJ. Maternal
thrombophilias are not associated with early pregnancy loss. Thromb
Haemost. 2004;91(2):290-5.
25. Clark P, Walker ID, Govan L, Wu O, Greer IA. The GOAL study: a
prospective examination of the impact of factor V Leiden and ABO(H)
blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J
Haematol. 2008;140(2):236-40.
26. Sarig G, Vidergor G, Brenner B. Assessment and management of
high-risk pregnancies in women with thrombophilia. Blood Rev.
2009;23(4):143-7.
27. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J,
et al. Increased fetal loss in women with heritable thrombophilia.
Lancet. 1996;348(9032):913-6.
28. Yamada H, Kato EH, Kobashi G, Ebina Y, Shimada S, Morikawa M, et al.
Recurrent pregnancy loss: etiology of thrombophilia. Semin Thromb
Hemost. 2001;27(2):121-9.
29. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al.
Thrombophilia in pregnancy: a systematic review. Br J Haematol.
2006;132(2):171-96.
30. Said JM, Higgins JR, Moses EK, Walker SP, Borg AJ, Monagle PT, et
al. Inherited thrombophilia polymorphisms and pregnancy outcomes in
nulliparous women. Obstet Gynecol. 2010;115(1):5-13.
31. Bouvier S, Cochery-Nouvellon E, Lavigne-Lissalde G, Mercier E,
Fabbro-Peray P, Balducchi JP, et al. Comparative incidence of pregnancy
outcomes in thrombophilia-positive women from the NOH-APS observational
study. Blood. 2014;123(3):414-21.
32. Rozano-Gorelick A, Papadakis E, Brenner B. Combined thrombophilia
and obstetric complications. Open Atheroscl Thromb J. 2009;2(1):38-41.
33. Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, Ron-El R.
Hypercoagulable thrombophilic defects and hyperhomocysteinemia in
patients with recurrent pregnancy loss. Am J Reprod Immunol.
2001;45(2):65-71.
34. Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple
thrombophilic gene mutations rather than specific gene mutations are
risk factors for recurrent miscarriage. Am J Reprod Immunol.
2006;55(5):360-8.
35. Couto E, Nomura ML, Barini R, Pinto e Silva JL. Pregnancy-associated
venous thromboembolism in combined heterozygous factor V Leiden and
prothrombin G20210A mutations. Sao Paulo Med J. 2005;123(6):286-8.
36. Zotz RB, Gerhardt A, Scharf RE. Inherited thrombophilia and
gestational venous thromboembolism. Best Pract Res Clin Haematol.
2003;16(2):243-59.
37. Lockwood CJ, Bauer KA. Inherited thrombophilias in pregnancy.
UpToDate. 2016.
38. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik
PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy:
Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest. 2012;141(2 Suppl):e691S-e736S.
39. Bujold E, Gouin K, Cote S. Low-molecular-weight heparin added to
aspirin in the prevention of recurrent early-onset pre-eclampsia in
women with inheritable thrombophilia: the FRUIT-RCT: a rebuttal. J
Thromb Haemost. 2012;10(6):1195; author reply 6.